Variational AI Releases Enki 4: Major Update to Foundation Model for Small-Molecule Drug Discovery

Variational AI introduces Enki™ 4: an improved algorithm and architecture designed to scale, expanding the pre-trained target coverage from 592 to 760 and now applicable to proximity-based therapeutics and novel payloads for antibody drug conjugates